Latest Regulatory News

European Lithium Limited reported strong Q2 2025 progress with significant share sales in Critical Metals Corp raising over A$12.8 million, alongside promising exploration and development updates across Greenland, Austria, Ireland, and Australia.

Environmental Clean Technologies Limited has secured crucial regulatory approvals for its Bacchus Marsh fertiliser facility and completed a $275K capital raise, while deferring field trials to better align with cropping cycles. The company is also undergoing significant restructuring to improve capital efficiency and focus on strategic growth.

Bowen Coking Coal Limited remains suspended from ASX trading following its failure to update on funding and debt plans, compounded by the appointment of voluntary administrators.

Citigold Corporation Limited reports steady progress in exploration and mine design at its Charters Towers Gold Project, while actively pursuing funding partnerships to restart operations.

Memphasys Limited has submitted its Felix™ sperm separation system for CE Mark approval, targeting Europe’s $5 billion IVF market, while expanding direct sales in Japan and validating its RoXsta™ oxidative stress diagnostic platform.

Prodigy Gold has successfully raised over $7 million through a combined entitlement offer and placement, with Plutus Prospecting increasing its voting power to 19.9%. The funds will fuel exploration and development in the prolific Tanami Gold Province.

Diatreme Resources has achieved a significant milestone with its Northern Silica Project awarded Major Project Status and a 278% upgrade in its Si2 Deposit resource, positioning the company for long-term growth in the critical minerals sector.

Ballymore Resources’ latest drilling at the Dittmer Project in North Queensland confirms expanding high-grade gold, silver, and copper mineralisation, with promising deep extensions identified. The company is advancing towards mining lease approval to unlock further underground exploration.

Alterity Therapeutics has secured U.S. FDA Fast Track designation for its drug ATH434 targeting Multiple System Atrophy, supported by promising Phase 2 clinical trial data showing slowed disease progression and a solid safety profile.

Magnis Energy Technologies progresses detailed engineering on its Nachu Graphite Project and moves to fast track US anode material production, while navigating ASX suspension and IM3NY bankruptcy fallout.

Codeifai Limited has raised $2.35 million through a share placement to fund key acquisitions and expand its footprint in quantum computing and AI. The move signals a strategic push towards U.S. market engagement and commercialisation of cutting-edge technology.

Uscom Limited reported a significant revenue decline in Q4 2025 amid global market instability but is focusing on cost management and strategic partnerships to position for recovery.